Navigation Links
disclosed in Medical News

CareFusion Issues Update Regarding Previously Disclosed June 12, 2009 Recall of the Alaris(R) System

SAN DIEGO, July 29 /PRNewswire/ -- CareFusion Corporation, which is expected to become a public company following its planned spinoff from Cardinal Health, today issued the following update regarding its previously disclosed recall of the Alaris System: On June 12, 2009, the ...

AIM Health Group Inc. and Med-Emerg International Inc. Announce Completion of Previously Disclosed Merger Transaction

AIM and MedEmerg Combine to Form One of the Largest Medical Health Services Companies in Canada TORONTO, Jan. 20 /PRNewswire-FirstCall/ - AIM Health Group Inc ("AIM") (TSX: AHG-V), a fully integrated health care company, and Med-Emerg International Inc. ("MedEmerg") (OTCBB: MDER), o...

Previously Disclosed Changes in Board Composition of NightHawk Radiology Holdings, Inc. Prompt Notice of Noncompliance from the Nasdaq Global Market

COEUR D'ALENE, Idaho, March 12 /PRNewswire-FirstCall/ -- As previously disclosed in its Form 8-K filed on February 28, 2008, NightHawk Radiology Holdings, Inc. (Nasdaq: NHWK ) announced that Ernest G. Ludy has resigned from his position as a member of the company's Board of Directors for pers...

HealthSouth Announces Final Agreement on Previously Disclosed Settlement with Federal Government

BIRMINGHAM, Ala., Dec. 14 /PRNewswire-FirstCall/ -- HealthSouth Corporation (NYSE: HLS ) today announced it has signed a definitive agreement with the United States Department of Justice on behalf of the Office of Inspector General (OIG-HHS) of the Department of Health and Human Services (HHS...

2007 Life Sciences Compensation Findings Disclosed www.compstudy.com

BOSTON, Nov. 27 /PRNewswire/ -- J. Robert Scott, a leading retainer-based executive search firm; Ernst & Young, a global leader in professional services; and the internationally recognized law firm of WilmerHale; in collaboration with professors from Harvard Business School, have released data...

Symmetry Medical Provides Update of Previously Disclosed Accounting Review at Sheffield, UK Operating Unit

WARSAW, Ind., Nov. 12 /PRNewswire-FirstCall/ -- Symmetry Medical Inc. (NYSE: SMA ), an independent provider of products to the global orthopedic device industry and other medical markets, today issued an update of the previously announced review of accounting irregularities at its Sheffield, ...

Bristol-Myers Squibb Finalizes Settlement of Previously Disclosed Federal Investigation into Pricing, Sales and Marketing Practices

NEW YORK, Sept. 28 /PRNewswire-FirstCall/ -- Bristol-Myers Squibb Company (NYSE: BMY ) announced today that it has finalized a civil settlement agreement with the United States Department of Justice ("DOJ") and the Office of the United States Attorney for the District of Massachusetts resolvi...

Should Genetic Information Be Disclosed to Insurers?

There is no good reason to deny insurers access to genetic information, argues a Professor of Ethics in a debate published in this weeks BMJ. Only if we refuse to give insurers access to all health information can we reasonably stop them seeking genetic test results, says Professor Soren H...

Brain Cell Repair Loss disclosed

According to researchers at the University of Stanford, have discovered the point of no return stage at which adult brain cells lose the ability to repair themselves. The investigators said their work should help find new opportunities to reverse this regeneration loss and speed nerve cell growth. ...

Transition Therapeutics to Present at Canaccord Adams 29th Annual Global Growth Conference

...tained in our press releases should be considered accurate only as of the date of the release and may be superseded by more recent information we have disclosed in later press releases, filings with the OSC, SEC or otherwise. Except for historical information, this press release may contain forward-looking sta...
disclosed in Medical Technology

MicroRNA First Disclosed by Rosetta Genomics may Increase Efficacy of Imatinib (Gleevec(R)(1)) in Glioblastoma

REHOVOT, Israel and JERSEY CITY, New Jersey, September 18 /PRNewswire-FirstCall/ -- - A Collaborative Study by Scientists at the Weizmann Institute of Science and Scientists at Sheba Medical Center, With the aid of Rosetta Genomics, Demonstrated That Overexpression of miR-451 Inhibited Growth ...

Cyberonics Provides Update on Depression Post-Approval Study

...suppliers and manufacturers for certain components; the accuracy of management's estimates of future expenses and sales; the results of the previously disclosed governmental inquiries; the potential identification of material weaknesses in our internal controls over financial reporting; risks and costs associa...

Leading Experts Endorse Bioheart's Muscle Stem Cell MyoCell Therapy

...t the patients have to get into this study." Bioheart's latest Phase II/III MARVEL study has undergone interim analysis and although data are not disclosed due to pending publication confidentiality, the panel of experts has reviewed these data and has unanimously and enthusiastically endorsed moving forw...

Arena Pharmaceuticals Announces Lorcaserin Data Demonstrating Highly Significant Categorical and Absolute Weight Loss and Improvements in Secondary Endpoints Associated with Cardiovascular Risk

...rators. Additional factors that could cause actual results to differ materially from those stated or implied by Arena's forward-looking statements are disclosed in Arena's filings with the Securities and Exchange Commission. These forward-looking statements represent Arena's judgment as of the time of this rel...

Arena Pharmaceuticals Announces the Presentation of Lorcaserin Phase 3 BLOOM Data at the American Diabetes Association's 69th Scientific Sessions

...rators. Additional factors that could cause actual results to differ materially from those stated or implied by Arena's forward-looking statements are disclosed in Arena's filings with the Securities and Exchange Commission. These forward-looking statements represent Arena's judgment as of the time of this rel...

Novavax Completes Enrollment of Its Second Phase II Seasonal Influenza VLP Vaccine Clinical Trial

...ing is required before regulatory approval can be applied for and the FDA may not approve a vaccine even if further trial results are similar to those disclosed previously by the company; uncertainties relating to clinical trials; dependence on the efforts of third parties; competition for clinical resources a...

FDA Accepts Arno Therapeutics' IND for AR-12 a PDK1 Inhibitor That Blocks the PI3K/Akt Pathway

...o place undue reliance on our forward-looking statements. Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements we make. Various important factors that could cause actual results or events to differ materially from the forward-...

One Step Closer: Novel Opioid Receptor Compound in Phase I Clinical Trials

...blishing their own companies on the side. But the Bayh-Dole Act passed in 1980 opened up new avenues by allowing universities to keep discoveries disclosed using federal grants instead of returning them to the government, often to languish. The law brought new incentives to commercialize discoveries, alon...

HeartWare International Clinical Trial Shows 90% Survival at 180 Days

...herwise. We may not actually achieve the plans, projections or expectations disclosed in forward-looking statements, and actual results, developments or events could differ materially from those disclosed in the forward-looking statements. Forward-looking statements are subject t...

American Lung Association Study to be Published in the 'New England Journal of Medicine' Finds Prescription Heartburn Medication Does Not Control Asthma Symptoms as Previously Thought

...atment with proton pump inhibitors does not improve control. Silent GER is not a likely cause of poorly controlled asthma. Norman H. Edelman, MD, disclosed stock ownership with Johnson & Johnson. About the American Lung Association: Now in its second century, the American Lung Association is t...
disclosed in Biological News

New results validating Pall prion reduction filter disclosed at ISBT Congress

Safety in transfusion medicine is an ongoing challenge to blood services worldwide as new threats, such as variant Creutzfeldt-Jakob Disease (vCJD), emerge. An update on the latest measures to protect the public from the human form of Bovine Spongiform Encephalopathy (BSE), commonly called Mad Cow ...

Entrust Announces Financial Results for Fourth-Quarter and Fiscal 2008

..., as well as adjusting for currency effects to maintain a constant currency with the prior year's results. The non-GAAP financial measures disclosed by the company should not be considered a substitute for, or superior to, financial measures calculated in accordance with GAAP, and the finan...

American Chemical Society's Weekly PressPac -- Dec. 3, 2008

...gistry Number 1073662-18-6 was assigned to a novel organic azulenobenzofuran derivative. CAS REGISTRY , the world's most authoritative collection of disclosed chemical substance information, now includes 40 million organic and inorganic substances . CAS - Science Connections is a series of articles...

Orchid Cellmark Reports Third Quarter 2008 Financial Results

...ould be considered accurate only as of the date of the release. Information in any press release may be superseded by more recent information we have disclosed in later press releases, filings with the Securities and Exchange Commission or otherwise. Press releases may contain forward-looking statements based...

A reputation for innovation

...de range of scientific disciplines from nanotechnology to biomedical engineering." Tech had a total of 27 Reports of Invention (ROI) this past year disclosed to the OIPC. This averages out to about 20 ROIs per $10 million R&D expenditures, which is approximately five times the national average. Six new p...

Genes may make some people more prone to anxiety

...rtle reflex in the unpleasant-picture condition than did carriers of either two copies of Val158 allele or one copy of each. The two-Met carriers also disclosed greater anxiety on a standard personality test. This finding confirms that specific variations in the gene that regulates dopamine signaling may pl...

Nobel laureate Dr. Linda Buck elected to American Academy of Arts & Sciences 2008 Class of Fellows

..., is the fifth Hutchinson Center researcher to be elected for AAAS membership. She was a senior postdoctoral researcher in Axels laboratory when she disclosed the nature of the olfactory receptors, and they co-published this work in 1991. Their work is the first to define one of our sensory systems in the mo...

How to stop regaining weight? That's the real question

...ssor Wim Saris, Executive Director of the entire Diogenes project concludes: "Preliminary results from the Diogenes dietary intervention study will be disclosed at the European Congress of Obesity (ECO) (14 May 2008) with results of the entire project being presented at the Diogenes satellite on 5/6 May 2009 a...

OHSU turns innovations into commercial opportunities at record pace

...s success in fostering innovation and entrepreneurship, fiscal year 2007 was a banner year for Oregon Health & Science University. OHSU researchers disclosed 132 inventions, more than in any previous year in the universitys historyand four times the number in 2000. Five new startup companies based on O...

H5N1 avian flu virus vaccine induces immune responses in healthy adults

...tes of Health, funded the study, published in the current issue of The New England Journal of Medicine. Preliminary results from this trial were first disclosed late last summer. "These findings represent an important step forward in the nation's efforts to prepare for the possible emergence of a human pand...
disclosed in Biological Technology

KV Pharmaceutical Announces Stockholder Action to Amend By-Laws is Invalid

...sons, which are available on the SEC's EDGAR website at www.sec.gov , also disclosed that such Reporting Persons have executed and delivered to the Company a pu...he satisfaction or waiver of the other closing conditions in the previously disclosed Gestiva(TM) acquisition agreement; (20) the possibility that the auction ra...

NxStage Reports Second Quarter 2009 Financial Results

... principles in the United States and may be different from similar non-GAAP financial measures used by other companies. The non-GAAP financial measure disclosed by the Company is not meant to be considered superior to or a substitute for results of operations prepared in accordance with GAAP. Management uses A...

Nile Therapeutics, Inc. Announces Dosing of First Patient in Phase 2 Study of CD-NP for the Treatment of Acute Heart Failure

...lace undue reliance on Nile's forward-looking statements. Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements Nile makes. Various important factors that could cause actual results or events to differ materially from the forwar...

Purdue Pharmaceutical Products L.P. and Transcept Pharmaceuticals, Inc. Sign Exclusive Agreement to Commercialize Intermezzo(R) in the United States

...y. Transcept may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements and you should not place undue reliance o... events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements we make. Various important factors could ...

Sunesis Receives Approval for Listing on The NASDAQ Capital Market

...NASDAQ through August 2, 2009. As a result of the market transfer, Sunesis is no longer subject to delisting from NASDAQ as a result of the previously disclosed stockholders' equity deficiency as of December 31, 2008, but it will need to comply with The NASDAQ Capital Market's continued listing requirements on...

Sunesis Reports Financial Results for the Second Quarter 2009

...Q through August 2, 2009. If the application is approved, the company will no longer be subject to delisting from NASDAQ as a result of the previously disclosed stockholders' equity deficiency as of December 31, 2008, but it will need to comply with The NASDAQ Capital Markets' continued listing requirements on...

Sanofi-aventis Announces Second Quarter 2009 Results

...ll be available in the 2009 Half-Year Financial Report. From 2010, financial communications issued by sanofi-aventis will comment on the new indicator disclosed for segment reporting purposes ("Economic net income - Pharmaceuticals, Vaccines and Other"). Use of this indicator will not give rise to any ...

Anesiva Receives NASDAQ Delisting Staff Determination Letter

... SOUTH SAN FRANCISCO, Calif., July 23 /PRNewswire-FirstCall/ -- Anesiva, Inc. (Nasdaq: ANSV ) received, as previously disclosed on its Current Report on Form 8-K filed with the Securities and Exchange Commission on April 2, 2009 and in its press release on April 1, 2009, a lett...

Nile Therapeutics, Inc. Completes $3.4 Million Private Placement

...lace undue reliance on Nile's forward-looking statements. Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements Nile makes. Various important factors that could cause actual results or events to differ materially from the forwar...

EnVivo Pharmaceuticals Announces Reversal of Cognitive Deficits in Alzheimer's Disease Transgenic Mouse Model With Gamma-Secretase Modulator

...ts observed in an Alzheimer's disease transgenic animal model after chronic oral dosing of a proprietary gamma-secretase modulator (GSM). The data was disclosed as part of the preclinical characterization of the development candidate EVP-0962. EVP-0962 is a proprietary small molecule that belongs to...
disclosed in Biological Dictionary

Xanthophyll

...icle on xanthophyll (pigment), ...distributed in living things. There are two major types: the hydrocarbon class, or carotenes, ... The invention disclosed in this application relates to a process for the preparation of xanthophyll crystals containing at least 85% total xanthophylls with at least ... ...

Topoisomerase

...EC 5.99.1.3 - DNA topoisomerase (ATP-hydrolysing) ... Topoisomerase II. Paramecium bursaria Chlorella virus 1. 661177. Topoisomerase II ... disclosed is a human is a hTopI-α polypeptide and DNA (RNA) encoding such hTopI-α polypeptide. ... Type I topoisomerase recognizes double-stranded DNA but...

Saturation mutagenesis

...ree trial, credit card req'd. Find Plant Physiology articles plus many other academic journal articles, magazine articles & newspaper archives. disclosed is a rapid and facilitated method of producing from a parentlal template polynucleotide, a set of ... DiMaio, " Saturation mutagenesis using ... ...

Polypeptide

... acquired NeoMPS from Isochem. ... The present invention provides a polypeptide inducing the production of an ... However, even the polypeptide disclosed in the above reference does not have ... Britannica online encyclopedia article on polypeptide (biochemistry), ...oxygen to the tissues. Hemoglob...

Hemizygous

... research, information, analysis and reviews from Psychology Journals, Newspapers, and magazines at HighBeam.com. Free Trial, Credit Card Required. disclosed are methods and reagents for detecting nucleotide mismatches (for example, due to sequence variances) in a ... one of said hemizygous cells is...

Base sequence analysis

...thod for determining the base ... An indispensable technique for base sequence analysis . Enzyme. A catalyst made by organisms. ... There is disclosed a method for determining the identity of one or more mutations or single nucleotide polymorphisms ... of the base sequence of the DNA. ... ...

Ampulla

..... Ampulla means flask like dilatation (spreading or stretching) of a tubular structure. May refer to Ampulla of ... The biopsy of the specimen disclosed an adenocarcinoma of the ampulla of Vater. ... In multiple cancers including ampulla Vater carcinoma, gastrointestinal cancers ... Ampulla of...
Other Tags
(Date:12/25/2014)... December 25, 2014 When head lice hits ... in a frenzy to get rid of it while keeping ... in Coral Gables now have the solution right in their ... clinic location, Lice Troopers provides full spectrum head lice screening ... Gable area, including Sunset, Key Biscayne, Brickell, Coconut Grove, Kendall, ...
(Date:12/25/2014)... -- Among early stage breast cancer patients who undergo ... percent will eventually develop leukemia as a result of ... comes from a review of more than 20,000 breast ... suggests that the risk for developing treatment-related leukemia, though ... "The frequency of bone marrow cancers such as ...
(Date:12/25/2014)... California (PRWEB) December 25, 2014 Plugin ... of ProFire 5k. A fully customizable business presentation tool ... , “Adding the ProFire 5k business tool, users can ... Christina Austin, CEO of Pixel Film Studios. “ProFire 5k ... and style to add professionalism to a presentation” , ...
(Date:12/24/2014)... Over 700 toys, that’s what ... That is 700 smiling little faces this holiday that ... $6000 in monetary donations was given to the various ... expenses they incur through the year. Some of the ... Child's Haven , Shrine's Children's Hospitals, Toys for Tots ...
(Date:12/24/2014)... 24, 2014 New studies reveal that women ... loss related depression (March 6, 2014, JAMA Otolaryngology*). And although ... loss (about 50 percent according to recent polls) facing hearing ... how a person feels and relates to the world. People ... are also made by way of:, , ...
Breaking Medicine News(10 mins):Health News:Coral Gables Florida Gets Ready to Be Lice-Free with Lice Troopers 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 3Health News:Announcing a new ProFire 5k plugin from Pixel Film Studios for Final Cut Pro X Professionals 2Health News:AlignLife Donates Over 700 Toys This Year 2Health News:Recent Studys Underscore the Fact That One of the Best Gifts to Give This Holiday Season is a Hearing Test 2Health News:Recent Studys Underscore the Fact That One of the Best Gifts to Give This Holiday Season is a Hearing Test 3Health News:Recent Studys Underscore the Fact That One of the Best Gifts to Give This Holiday Season is a Hearing Test 4Health News:Recent Studys Underscore the Fact That One of the Best Gifts to Give This Holiday Season is a Hearing Test 5Health News:Recent Studys Underscore the Fact That One of the Best Gifts to Give This Holiday Season is a Hearing Test 6
(Date:12/10/2014)... , Dec. 9, 2014 CIE San ... catalyst that provides the connective tissue that enhances care ... them to easily share client-level information; earned a second ... expand to organizations serving seniors aging in community and; ... partner on December 11 th 4-6p. ...
(Date:12/10/2014)... 9, 2014     ...   Jifflenow, a ... solutions for business-to-business (B2B) events, today announced a ... mobile near-field communication (NFC), Bluetooth low energy (BLE), ... http://photos.prnewswire.com/prnh/20140612/691055) , Jifflenow will integrate its ...
(Date:12/5/2014)... -- Tute Genomics, a leader in cloud-based solutions for genome ... led by UK-based Eurovestech. Peak Ventures and a number ... "We are at a pivotal time in ... seeks new approaches for the diagnosis, treatment and prevention ... and CEO of Tute Genomics. "One of the main ...
Breaking Biology News(10 mins):Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 3Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 2Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 3
Other Contents